Apitoria Pharma
Apitoria Pharma, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of high-quality generic medications and active pharmaceutical ingredients (APIs). With a commitment to innovation, Apitoria Pharma offers a diverse portfolio of products that cater to therapeutic areas such as oncology, cardiology, and infectious diseases. Their unique approach to research and development has led to several key milestones, including the successful launch of multiple complex generics. Recognised for its robust quality standards and regulatory compliance, Apitoria Pharma continues to strengthen its market position, making significant contributions to global healthcare while ensuring accessibility to essential medicines.
DitchCarbon Score
How does Apitoria Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Apitoria Pharma's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Apitoria Pharma's reported carbon emissions
Apitoria Pharma, headquartered in India, currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This includes setting science-based targets for emissions reductions and engaging in initiatives aimed at minimising their carbon footprint. Apitoria Pharma may be aligning with these industry trends, but specific commitments or targets have not been disclosed.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Apitoria Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
